MedAdNews

2019 Agency of the Year

Speak directly and say only what you mean. Be loyal to the things you say you are going to do. Keep your promises.

Dudnyk Wins Two Pharma Choice Awards from PM360

Simon’s Heart awarded Gold and Eyevance earns Silver.

The Rise of the Empowered Patient

Many of the rare disease advocacy groups that exist today were started or inspired by parents looking to draw attention and resources to their children’s conditions, and their passion and hard work

The Implementation of Universal Genetic Screening

Genetic screening offers a powerful insight into our genome, which, by identifying thousands of genetic diseases, will help lead to improved patient care and treatment, and also to the next wave of

Can Healthcare Be Equitable?

Even with these unparalleled strengths, millions of people struggle each day to gain access to the best treatments and to pay for their medication, and feel unprotected by our healthcare system.

The Need for Education

As industry leaders, we should be breaking down these barriers and driving patients to the answers they need, and ultimately, to life-changing treatments.

How to attract the workforce of the future

Laurie Bartolomeo shares her thoughts on how to inspire the next generation in the December issue of PharmaVOICE.

Ten Things Every Family Living with a Rare Disease Needs to Know

In the December issue of PM360, Laurie Bartolomeo lists ten ways that companies, marketers, and HCPs can empower patients and families living with rare disease.

MM&M Partner Forum: Not really that rare

Chris Tobias reveals how Dudnyk supports our clients in the rare disease space. Earning trust must come first.

Dudnyk Wins PM360 Trailblazer Award for Philanthropic Initiative

Simon’s Heart awarded Best Consumer Website/Online Initiative

Dudnyk's Tim Anderson on the Enduring Value of Chemotherapy in Cancer Care

In the new age of innovative oncology therapies, chemotherapy still plays a critical role in cancer care.

Agency CEO Roundtable

In the September issue of PharmaVOICE, Chris Tobias discusses why the strength of the empowered patient is the greatest fundamental shift in our industry.

Dudnyk Named Finalist for Multiple Trailblazer Awards

Dudnyk is proud to have been named a finalist five times for the upcoming PM360 Magazine #TrailblazerAwards.

Drew Desjardins Named to PharmaVOICE 100

Drew Desjardins has been recognized as one of the inspirational leaders of our industry. Read what our “Chief Problem Solver” has to say about collaborative thinking and groundbreaking strategy.

Dudnyk Shortlisted for Four MM&M Awards

Dudnyk has been nominated in four categories for this year’s MM&M Awards, including for our philanthropic and rare disease work.

Dudnyk Listed as Top 100 Agency in July MM&M

Dudnyk has been listed again in the annual agency issue. Read to learn more about our revenue increases, recent growth, and ongoing projects.

From Isolation to Anticipation

Laurie Bartolomeo shares how technology continues to improve the lives of rare disease families in the July issue of MedAd News.

WOW! Laurie Bartolomeo Featured in PharmaVOICE Woman of the Week Podcast

Laurie Bartolomeo talks to PharmaVOICE about her career journey and how her son’s rare disease is a source of inspiration.

Dudnyk Featured in April Med Ad News

The April agency issue of Med Ad News highlighted Dudnyk as Agency of the Year.

Dudnyk Named Agency of the Year

Agency Earns Top Honors from Med Ad News at the 30th Annual Manny Awards.

Patient Journeys Are Never Linear

Drew Desjardins talks about why no two rare disease journeys are ever alike in the April issue of PharmaVOICE.